NasdaqGS:ALKSBiotechs
Is Alkermes (ALKS) Offering Value After Recent Share Price Weakness And DCF Upside Signals
If you are wondering whether Alkermes at around US$27.77 is offering genuine value or just looks cheap on the surface, you are in the right place.
The share price has seen a 5.2% decline over the last week, a 20.3% decline over the last month and is also down 1.7% year to date and 16.9% over the past year, even though the 3 year and 5 year returns sit at 6.0% and 40.0% respectively.
These mixed return numbers sit against an ongoing backdrop where investors are reassessing risk and potential...